A detailed history of Tower Research Capital LLC (Trc) transactions in Exact Sciences Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,104 shares of EXAS stock, worth $64,153. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,104
Previous 34,974 96.84%
Holding current value
$64,153
Previous $1.48 Million 94.92%
% of portfolio
0.0%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$42.43 - $70.83 $1.44 Million - $2.4 Million
-33,870 Reduced 96.84%
1,104 $75,000
Q2 2024

Aug 13, 2024

BUY
$41.33 - $74.26 $1.23 Million - $2.21 Million
29,719 Added 565.54%
34,974 $1.48 Million
Q1 2024

May 15, 2024

SELL
$56.27 - $73.77 $9,059 - $11,876
-161 Reduced 2.97%
5,255 $362,000
Q4 2023

Feb 13, 2024

BUY
$59.06 - $75.72 $281,539 - $360,957
4,767 Added 734.51%
5,416 $400,000
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $299,631 - $450,037
-4,544 Reduced 87.5%
649 $44,000
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $726,774 - $1.1 Million
-11,595 Reduced 69.07%
5,193 $487,000
Q1 2023

May 09, 2023

BUY
$47.19 - $70.77 $762,920 - $1.14 Million
16,167 Added 2603.38%
16,788 $1.14 Million
Q4 2022

Feb 10, 2023

SELL
$30.35 - $53.15 $1.84 Million - $3.21 Million
-60,466 Reduced 98.98%
621 $31,000
Q3 2022

Nov 10, 2022

BUY
$31.97 - $49.37 $1.58 Million - $2.44 Million
49,334 Added 419.76%
61,087 $1.99 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $271,027 - $580,186
7,611 Added 183.75%
11,753 $463,000
Q1 2022

May 12, 2022

SELL
$57.56 - $82.54 $57,847 - $82,952
-1,005 Reduced 19.53%
4,142 $289,000
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $54,810 - $76,114
756 Added 17.22%
5,147 $400,000
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $359,967 - $494,835
3,989 Added 992.29%
4,391 $419,000
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $3.09 Million - $4.6 Million
-33,022 Reduced 98.8%
402 $50,000
Q1 2021

May 17, 2021

BUY
$116.57 - $155.01 $2.42 Million - $3.22 Million
20,758 Added 163.89%
33,424 $4.41 Million
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $672,367 - $959,310
6,750 Added 114.1%
12,666 $1.68 Million
Q3 2020

Nov 16, 2020

BUY
$72.92 - $102.01 $413,018 - $577,784
5,664 Added 2247.62%
5,916 $603,000
Q2 2020

Aug 13, 2020

BUY
$55.75 - $92.75 $14,049 - $23,373
252 New
252 $22,000
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $15,539 - $42,820
-410 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$77.66 - $99.74 $99,327 - $127,567
-1,279 Reduced 75.73%
410 $38,000
Q3 2019

Nov 05, 2019

BUY
$90.37 - $122.49 $152,634 - $206,885
1,689 New
1,689 $153,000
Q2 2019

Aug 13, 2019

SELL
$89.51 - $118.04 $4,923 - $6,492
-55 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$61.98 - $96.5 $1,425 - $2,219
23 Added 71.88%
55 $5,000
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $51,052 - $75,303
-911 Reduced 96.61%
32 $2,000
Q3 2018

Nov 13, 2018

SELL
$48.29 - $80.6 $166,214 - $277,425
-3,442 Reduced 78.49%
943 $74,000
Q2 2018

Aug 15, 2018

BUY
$37.84 - $69.96 $165,928 - $306,774
4,385 New
4,385 $262,000
Q4 2017

Feb 09, 2018

SELL
$46.49 - $60.51 $334,542 - $435,429
-7,196 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $266,611 - $339,075
7,196
7,196 $339,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.